Daiwa Securities Group’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2
| Closed | – | – | 1401 |
|
|
2023
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 1360 |
|
|
2023
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 1364 |
|
|
2023
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 1318 |
|
|
2022
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 1400 |
|
|
2022
Q3 | $1K | Hold |
2
| – | – | ﹤0.01% | 1316 |
|
|
2022
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 1436 |
|
|
2022
Q1 | $1K | Hold |
2
| – | – | ﹤0.01% | 1348 |
|
|
2021
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 1455 |
|
|
2021
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 1342 |
|
|
2021
Q2 | $1K | Hold |
2
| – | – | ﹤0.01% | 1225 |
|
|
2021
Q1 | $1K | Hold |
2
| – | – | ﹤0.01% | 1239 |
|
|
2020
Q4 | $1K | Sell |
2
-2
| -50% | -$1K | ﹤0.01% | 1220 |
|
|
2020
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 1162 |
|
|
2020
Q2 | $1K | Hold |
4
| – | – | ﹤0.01% | 1180 |
|
|
2020
Q1 | $1K | Hold |
4
| – | – | ﹤0.01% | 1189 |
|
|
2019
Q4 | $2K | Hold |
4
| – | – | ﹤0.01% | 1162 |
|
|
2019
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 1150 |
|
|
2019
Q2 | $1K | Hold |
4
| – | – | ﹤0.01% | 1170 |
|
|
2019
Q1 | $2K | Buy |
+4
| New | +$2K | ﹤0.01% | 1131 |
|